Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
rhTPO
The First People's Hospital of Lianyungang
Thrombocytopenia
1 trial -
rhTPO
The First People's Hospital of Lianyungang
Primary Immune Thrombocytopenia
1 trial -
risperidone
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Neuroleptic-Induced Tardive Dyskinesia
1 trial -
rituximab combined with corticosteroids
The First People's Hospital of Lianyungang
Primary Membranous Nephropathy
1 trial -
ropivacaine
The First People's Hospital of Lianyungang
Injury of Upper Limb
1 trial -
semaglutide combined with metformin
The First People's Hospital of Lianyungang
Osteoporosis
1 trial -
sodium oxybate
Jazz Pharmaceuticals Ireland Limited
Sleep
1 trial -
sodium valproate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epilepsy
1 trial -
sodium zirconium cyclic silicate
The First People's Hospital of Lianyungang
Potassium Imbalance
1 trial -
tasimelteon 20 mg capsule
Vanda Pharmaceuticals Netherlands B.V.
Non-24-Hour-Sleep-Wake Disorder
1 trial -
ticagrelor
The First People's Hospital of Lianyungang
Inflammation
1 trial -
tong-jiang granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome
1 trial -
trivalent seasonal influenza vaccine
Sinovac Research and Development Co.,
Influenza
1 trial -
turoctocog alfa
Novo Nordisk A/S
Congenital Bleeding Disorder
2 trials -
video capsule endoscopy
Hospital Authority, Hong Kong
Overt Obscure Gastrointestinal Bleeding
1 trial -
18F-FDG
The First People's Hospital of Lianyungang
Tumor, Solid
1 trial -
18F-PSMA-1007
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma
1 trial -
20 grams protein
United Therapeutics Europe Ltd
Muscle Disuse
1 trial -
24/7 EEG™ SubQ
COGNITION THERAPEUTICS INC
Sleep
1 trial -
2L PEG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bowel Preparation Scale
1 trial -
4D
4D Molecular Therapeutics
Dietary Supplementation
1 trial -
5-gene classification model
Hospital Authority, Hong Kong
ABO Blood Type Incompatible Kidney Transplantation
1 trial -
68Ga-DOTA-NT-20.3
The First People's Hospital of Lianyungang
Pancreatic Ductal Adenocarcinoma
1 trial -
68Ga-Her2-affibody
The First People's Hospital of Lianyungang
Neoplasms
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources